Cargando…
Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
BACKGROUND: The multi-arm multi-stage framework uses intermediate outcomes to assess lack-of-benefit of research arms at interim stages in randomised trials with time-to-event outcomes. However, the design lacks formal methods to evaluate early evidence of overwhelming efficacy on the definitive out...
Autores principales: | Blenkinsop, Alexandra, Parmar, Mahesh KB, Choodari-Oskooei, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442021/ https://www.ncbi.nlm.nih.gov/pubmed/30648428 http://dx.doi.org/10.1177/1740774518823551 |
Ejemplares similares
-
Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013) -
Treatment selection in multi-arm multi-stage designs: With
application to a postpartum haemorrhage trial
por: Choodari-Oskooei, Babak, et al.
Publicado: (2023) -
Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013) -
Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
por: Bratton, Daniel J., et al.
Publicado: (2016) -
Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)